WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2024)
Top pharmaceutical stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
KMDA
KAMADA LTD
Israel
$305.79M57,479,5289.87%0.00%
PCRX
PACIRA BIOSCIENCES INC
United States
$1.43B46,546,14868.87%31.13%Net SellingNet Selling
NBIX
NEUROCRINE BIOSCIENCES INC
United States
$14.03B100,637,22769.85%30.15%Net SellingNet Selling
LNTH
LANTHEUS HOLDINGS INC
United States
$5.64B69,312,58852.39%47.61%Net SellingNet Selling
AMPH
AMPHASTAR PHARMACEUTICALS INC
United States
$2.13B48,901,96549.24%50.76%Net SellingNet Buying
HCM
HUTCHMED (CHINA) LTD
Hong Kong
$3.43B871,256,2701.64%0.00%
ANIP
ANI PHARMACEUTICALS INC
United States
$1.29B20,972,51322.61%77.39%Net SellingNet Selling
COLL
COLLEGIUM PHARMACEUTICAL INC
United States
$1.12B32,715,32258.94%41.06%Net SellingNet Selling
SCYX
SCYNEXIS INC
United States
$95.58M37,779,79639.19%21.69%Net Selling
ZTS
ZOETIS INC
United States
$78.51B456,295,13792.07%5.64%Net SellingNet Selling
SIGA
SIGA TECHNOLOGIES INC
United States
$532.00M71,122,51635.21%64.79%Net SellingNet Selling
CRON
CRONOS GROUP INC
Canada
$1.07B382,011,17811.48%48.39%Net SellingNet Selling
ITCI
INTRA-CELLULAR THERAPIES INC
United States
$7.11B105,574,85578.00%22.00%Net SellingNet Selling
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
Israel
$1.61B37,587,23112.41%50.73%
RDY
DR REDDYS LABORATORIES LTD
India
$11.61B166,527,87614.16%0.00%
ALKS
ALKERMES PLC
Ireland
$4.10B169,221,31193.55%6.45%Net SellingNet Selling
TLRY
TILRAY BRANDS INC
Canada
$1.44B774,028,55811.04%1.99%Net Buying
DCPH
DECIPHERA PHARMACEUTICALS INC
United States
$2.20B86,475,97267.67%32.33%Net BuyingNet Buying
PROC
PROCAPS GROUP SA
Luxembourg
$315.91M112,824,1830.08%76.27%
ZOM
ZOMEDICA CORP
United States
$178.35M979,949,6688.58%6.92%Net BuyingNet Buying
SBFM
SUNSHINE BIOPHARMA INC
United States
$15.19M18,945,05230.20%21.14%Net BuyingNet Buying
HLN
HALEON PLC
United Kingdom
$39.25B9,234,573,8315.63%0.00%
ETON
ETON PHARMACEUTICALS INC
United States
$94.03M25,690,56227.96%21.84%
PAHC
PHIBRO ANIMAL HEALTH CORP
United States
$745.67M40,503,60844.63%55.37%
ACB
AURORA CANNABIS INC
Canada
$325.99M47,590,38211.96%0.00%
PBH
PRESTIGE CONSUMER HEALTHCARE INC
United States
$3.23B49,915,36668.82%31.18%Net SellingNet Selling
DVAX
DYNAVAX TECHNOLOGIES CORP
United States
$1.55B130,891,71072.74%27.26%Net SellingNet Selling
TLPH
TALPHERA INC
United States
$17.33M16,992,9779.46%90.54%Net BuyingNet Buying
TXMD
THERAPEUTICSMD INC
United States
$24.68M11,532,4433.69%96.31%Net Buying
EOLS
EVOLUS INC
United States
$810.18M62,610,48773.48%26.52%Net SellingNet Selling
UPC
UNIVERSE PHARMACEUTICALS INC
China
$9.08M3,645,9740.04%0.00%
TKNO
ALPHA TEKNOVA INC
United States
$69.81M40,823,38714.66%83.29%Net Buying
ORGO
ORGANOGENESIS HOLDINGS INC
United States
$373.85M132,572,4656.06%93.94%Net SellingNet Buying
EGRX
EAGLE PHARMACEUTICALS INC
United States
$49.48M12,986,97123.95%76.05%Net SellingNet Selling
OPTN
OPTINOSE INC
United States
$131.12M113,038,72669.35%30.65%Net SellingNet Selling
YCBD
CBDMD INC
United States
$2.74M3,869,0820.27%99.73%
EVOK
EVOKE PHARMA INC
United States
$3.88M8,597,40521.02%78.98%
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
China
$20.74M35,750,0000.11%0.00%
SUPN
SUPERNUS PHARMACEUTICALS INC
United States
$1.53B54,974,25445.05%54.95%Net SellingNet Selling
PRGO
PERRIGO CO PLC
Ireland
$4.00B136,320,43361.32%38.68%Net BuyingNet Buying
ESPR
ESPERION THERAPEUTICS INC
United States
$450.92M189,460,29366.12%20.74%Net SellingNet Selling
RMTI
ROCKWELL MEDICAL INC
United States
$54.87M30,315,68414.41%85.59%Net SellingNet Selling
INCR
INTERCURE LTD
Israel
$141.28M45,572,6897.74%0.00%
HUGE
FSD PHARMA INC
Canada
$13.75M40,429,6411.64%0.00%
AQST
AQUESTIVE THERAPEUTICS INC
United States
$286.77M91,038,53245.58%7.44%Net SellingNet Selling
PETQ
PETIQ INC
United States
$591.47M29,751,84783.52%16.48%Net SellingNet Selling
ALIM
ALIMERA SCIENCES INC
United States
$157.17M52,388,51328.94%71.06%Net BuyingNet Selling
ALVO
ALVOTECH
Luxembourg
$3.74B266,821,8445.34%0.00%
AYTU
AYTU BIOPHARMA INC
United States
$17.38M5,568,1585.73%94.27%Net Buying
GHSI
GUARDION HEALTH SCIENCES INC
United States
$11.69M1,284,1560.41%99.59%
DRRX
DURECT CORP
United States
$38.18M31,039,3818.83%91.17%
AVDL
AVADEL PHARMACEUTICALS PLC
Ireland
$1.52B96,118,52372.86%13.53%Net Selling
HROW
HARROW INC
United States
$609.28M35,381,93528.65%71.35%Net SellingNet Buying
RDHL
REDHILL BIOPHARMA LTD
Israel
$18.01M12,746,797,8000.02%0.00%
PTPI
PETROS PHARMACEUTICALS INC
United States
$4.55M7,000,1950.92%82.74%
SXTC
CHINA SXT PHARMACEUTICALS INC
China
$764.24k727,8510.39%0.00%
BFRI
BIOFRONTERA INC
United States
$5.80M5,089,41311.76%88.24%
ASRT
ASSERTIO HOLDINGS INC
United States
$98.93M95,124,60545.93%20.42%Net SellingNet Selling
DERM
JOURNEY MEDICAL CORP
United States
$71.05M20,012,8969.06%15.76%Net BuyingNet Buying
EBS
EMERGENT BIOSOLUTIONS INC
United States
$263.06M52,401,85042.47%57.53%Net SellingNet Selling
CYTH
CYCLO THERAPEUTICS INC
United States
$36.91M28,615,7403.12%96.88%Net Buying
VTRS
VIATRIS INC
United States
$12.95B1,190,675,81979.72%17.86%Net SellingNet Selling
CGC
CANOPY GROWTH CORP
Canada
$857.39M91,114,6047.49%92.51%Net Selling
INDV
INDIVIOR PLC
United Kingdom
$2.29B136,526,35747.78%0.00%
FLGC
FLORA GROWTH CORP
United States
$16.02M12,816,5352.78%57.12%Net BuyingNet Buying
CRDL
CARDIOL THERAPEUTICS INC
Canada
$139.73M64,097,53610.23%0.00%
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
Hong Kong
$71.05M13,012,8660.01%0.00%
OGI
ORGANIGRAM HOLDINGS INC
Canada
$177.60M94,468,55811.98%0.00%
CPIX
CUMBERLAND PHARMACEUTICALS INC
United States
$22.28M14,191,22915.24%58.39%Net BuyingNet Selling
CTLT
CATALENT INC
United States
$9.95B180,979,84977.50%22.50%Net BuyingNet Selling
LFCR
LIFECORE BIOMEDICAL INC
United States
$178.09M30,546,93649.55%50.45%
KALA
KALA BIO INC
United States
$18.34M2,816,4541.24%98.76%Net Selling
SNOA
SONOMA PHARMACEUTICALS INC
United States
$2.75M15,607,4331.05%24.91%
PRFX
PAINREFORM LTD
Israel
$1.39M1,850,2439.63%0.00%
TAK
TAKEDA PHARMACEUTICAL CO LTD
Japan
$40.98B1,569,013,4644.94%0.00%
IXHL
INCANNEX HEALTHCARE INC
Australia
$42.70M15,873,1134.04%27.69%
EVO
EVOTEC SE
Germany
$1.83B177,185,7362.79%0.00%
BHC
BAUSCH HEALTH COMPANIES INC
Canada
$2.34B366,796,72168.76%30.67%Net SellingNet Selling
IRWD
IRONWOOD PHARMACEUTICALS INC
United States
$1.03B158,957,12372.94%27.06%Net SellingNet Selling
AKAN
AKANDA CORP
United Kingdom
$813.54k8,842,8512.14%0.00%
ELAN
ELANCO ANIMAL HEALTH INC
United States
$8.37B494,181,62090.47%9.53%Net SellingNet Selling
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
United States
$7.24M16,794,8930.39%59.49%Net Selling
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Israel
$19.12B1,132,640,59750.24%0.96%Net SellingNet Selling
CPHI
CHINA PHARMA HOLDINGS INC
China
$5.03M15,870,0700.22%99.78%Net Buying
AMRX
AMNEAL PHARMACEUTICALS INC
$2.05B308,651,37325.00%75.00%Net SellingNet Selling
LSDI
LUCY SCIENTIFIC DISCOVERY INC
Canada
$2.15M1,764,6306.76%93.24%
BGXX
BRIGHT GREEN CORP
United States
$43.74M190,166,3185.61%67.06%Net Buying

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in May 2024?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the top pharmaceutical stock with a Zen Score of 65, which is 40 points higher than the pharmaceutical industry average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 9.47% over the past year, overperforming other pharmaceutical stocks by 14 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 106.77% from Kamada's current stock price of $5.32.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the second best pharmaceutical stock with a Zen Score of 64, which is 39 points higher than the pharmaceutical industry average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock return 49.12% over the past year, overperforming other pharmaceutical stocks by 53 percentage points.

Neurocrine Biosciences has an average 1 year price target of $159.06, an upside of 14.08% from Neurocrine Biosciences's current stock price of $139.43.

Neurocrine Biosciences stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Neurocrine Biosciences, 56.25% have issued a Strong Buy rating, 25% have issued a Buy, 18.75% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the third best pharmaceutical stock with a Zen Score of 64, which is 39 points higher than the pharmaceutical industry average of 25. It passed 20 out of 33 due diligence checks and has strong fundamentals. Pacira Biosciences has seen its stock lose -25.9% over the past year, underperforming other pharmaceutical stocks by -22 percentage points.

Pacira Biosciences has an average 1 year price target of $46.71, an upside of 52.06% from Pacira Biosciences's current stock price of $30.72.

Pacira Biosciences stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Pacira Biosciences, 28.57% have issued a Strong Buy rating, 71.43% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 8.02%, which is 5 percentage points higher than the pharmaceutical industry average of 2.98%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

2. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 4.42%, which is 1 percentage points higher than the pharmaceutical industry average of 2.98%.

Alkermes's dividend payout ratio of 40.8% indicates that its dividend yield is sustainable for the long-term.

3. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 3.73%, which is 1 percentage points higher than the pharmaceutical industry average of 2.98%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -1,825% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -0.23% in the last day, and down -0.84% over the last week. Eagle Pharmaceuticals was the among the top losers in the drug manufacturers - specialty & generic industry, dropping -12.81% yesterday.

Eagle Pharmaceuticals shares are trading lower after the company announced a Nasdaq listing receipt.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 82 points higher than the pharmaceutical industry average of 18. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -25.9% in the past year. It has underperformed other stocks in the pharmaceutical industry by -22 percentage points.

2. Collegium Pharmaceutical (NASDAQ:COLL)


Collegium Pharmaceutical (NASDAQ:COLL) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Collegium Pharmaceutical has a valuation score of 86, which is 68 points higher than the pharmaceutical industry average of 18. It passed 6 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 45.38% in the past year. It has overperformed other stocks in the pharmaceutical industry by 50 percentage points.

3. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Kamada has a valuation score of 86, which is 68 points higher than the pharmaceutical industry average of 18. It passed 6 out of 7 valuation due diligence checks.

Kamada's stock has gained 9.47% in the past year. It has overperformed other stocks in the pharmaceutical industry by 14 percentage points.

Are pharmaceutical stocks a good buy now?

58.49% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 32.89% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -1.12x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.